(2) what factors he takes into consideration when assessing recommendations from the Advisory Council on the Misuse of Drugs;
(3) on what basis he rejected the recommendation of the Advisory Council on the Misuse of Drugs that cannabis should remain a class C drug.
As my right hon. Friend the former Home Secretary, Member for Redditch (Jacqui Smith), advised in her statement to the House on 7 May 2008, Official Report, column 705, the reclassification of cannabis as a Class B drug against the advice of the Advisory Council on the Misuse of Drugs (ACMD) was based on a number of factors, including but not limited to scientific evidence. Reclassification on 26 January 2009 is a preventative measure to protect the public, particularly the future health of young people.
The Government’s Reply to the Fifth Report from the House of Commons Science and Technology Committee Session 2005-06 HC 1031 Drug classification: making a hash of it? can be found at:
sets out the factors, including the ACMD’s recommendations, that are considered in relation to drug classification decisions.
The Government have published and will continue to publish responses to the recommendations in the reports of Advisory Council on the Misuse of Drugs.